Cite
HARVARD Citation
Warnnissorn, N. et al. (2022). External validation and comparison of IPI, R-IPI, and NCCN-IPI in diffuse large B-cell lymphoma patients treated with R-CHOP to predict 2-year progression-free survival. Hematology. 27 (1), pp. 1237-1245. [Online].